[Effect of methotrexate on the leukemic cell cycle in mouse ascitic leukemia L1210].
In cells of L1210 ascite leukemia cells, methotrexate inhibited H3-thymidine incorporation, blocked shortly (during 4 hours) the G1 leads to S transition, and did not affect cells in G2-phase or in the late S phase. Almost half a cell population was degenerated and cells in S- and G1-phases were affected in equal proportion. This may suggest that methotrexate is not S-phase specific for cells of leukemia L1210. A simultaneous administration of vinblastine increases the antitumour effect of methotrexate. Cells in G2-phase constitute, presumably, a significant proportion of cells recovered after methotrexate administration. A comparison of the data obtained with literature evidence shows that in the sensitive (leukemia L1210) and resistant (acute mieloid leukemia of man) forms of leukemia, methotrexate affects cells that are in S-phase, whereas cells being in G1-phase are affected only when the sensitive tumours are treated.
D000818:Animals; D001202:Ascitic Fluid / Q000166:cytology / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D004351:Drug Resistance; D004357:Drug Synergism; D005260:Female; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000494:pharmacology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008938:Mitosis / Q000187:drug effects; D013936:Thymidine / Q000037:antagonists & inhibitors / Q000378:metabolism; D013997:Time Factors; D014747:Vinblastine / Q000494:pharmacology
D014747:Vinblastine; D013936:Thymidine; D008727:Methotrexate
Vliianie metotreksata na tsikl leĭkoznykh kletok astsitnoĭ leĭkemii L1210 mysheĭ